KHC vs URGN · P/E 12, rev $12.31B vs rev $123.4M
Kraft Heinz Co (KHC) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
KHC currently screens at market cap $31.55B and trailing P/E 12.2. URGN currently screens at market cap $1.61B.
Not investment advice. Open the KHC and URGN stock pages for the full models.
Not investment advice.